{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T16:01:45Z","timestamp":1772121705717,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.vaccine.2009.10.024","type":"journal-article","created":{"date-parts":[[2009,10,25]],"date-time":"2009-10-25T04:10:08Z","timestamp":1256443808000},"page":"834-839","source":"Crossref","is-referenced-by-count":58,"title":["Immunogenicity and safety of IXIARO\u00ae (IC51) in a Phase II study in healthy Indian children between 1 and 3 years of age"],"prefix":"10.1016","volume":"28","author":[{"given":"A.","family":"Kaltenb\u00f6ck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Dubischar-Kastner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Schuller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahima","family":"Datla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.S.","family":"Klade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.S.A.","family":"Kishore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.10.024_bib1","first-page":"63","article-title":"Japanese encephalitis","volume":"vol. III","author":"Burke","year":"1988"},{"key":"10.1016\/j.vaccine.2009.10.024_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/oxfordjournals.epirev.a036087","article-title":"The epidemiology of Japanese encephalitis: prospects for prevention","volume":"14","author":"Vaughn","year":"1992","journal-title":"Epidem Rev"},{"key":"10.1016\/j.vaccine.2009.10.024_bib3","first-page":"299","article-title":"Epidemiology and control of Japanese encephalitis","volume":"45","author":"Igarashi","year":"1992","journal-title":"World Health Stat Q"},{"key":"10.1016\/j.vaccine.2009.10.024_bib4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1086\/341247","article-title":"Japanese encephalitis vaccine for travellers: exploring the limits of risk","volume":"15","author":"Shlim","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2009.10.024_bib5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1086\/590116","article-title":"Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine","volume":"198","author":"Tauber","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.10.024_bib6","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/S0140-6736(07)61780-2","article-title":"Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial","volume":"370","author":"Tauber","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2009.10.024_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jcv.2008.05.001","article-title":"Japanese encephalitis in a Finnish traveler on a two-week holiday in Thailand","volume":"43","author":"Lehtinen","year":"2008","journal-title":"J Clin Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.10.024_bib8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/00365549609049074","article-title":"Fatal Japanese encephalitis in a Danish tourist visiting Bali for 12 days","volume":"28","author":"Buhl","year":"1996","journal-title":"Scand J Infect Dis"},{"issue":"8962","key":"10.1016\/j.vaccine.2009.10.024_bib9","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0140-6736(95)92990-8","article-title":"Japanese encephalitis after a 10-day holiday in Bali","volume":"345","author":"Wittesj\u00f6","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2009.10.024_bib10","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/0035-9203(69)90031-5","article-title":"Assay of arbovirus neutralizing antibody by micro methods","volume":"63","author":"Sukhavachana","year":"1969","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"49","key":"10.1016\/j.vaccine.2009.10.024_bib11","doi-asserted-by":"crossref","first-page":"8257","DOI":"10.1016\/j.vaccine.2007.09.052","article-title":"Japanese encephalitis vaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy","volume":"25","author":"Puthanakit","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2009.10.024_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3201\/eid1501.080311","article-title":"Past, present and future of Japanese encephalitis","volume":"15","author":"Erlanger","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2009.10.024_bib13","unstructured":"WHO. Weekly epidemiological record, no. 34\/35; 25 August 2006."},{"issue":"1","key":"10.1016\/j.vaccine.2009.10.024_bib14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-3156.2007.01967.x","article-title":"A decade of Japanese encephalitis surveillance in Sarawak, Malaysia: 1997\u20132006","volume":"13","author":"Wong","year":"2008","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.vaccine.2009.10.024_bib15","series-title":"Vaccines","first-page":"672","article-title":"Japanese encephalitis vaccines","author":"Tsai","year":"1999"},{"key":"10.1016\/j.vaccine.2009.10.024_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/oxfordjournals.epirev.a036087","article-title":"The epidemiology of Japanese encephalitis: prospects for prevention","volume":"14","author":"Vaughn","year":"1992","journal-title":"Epidemiol Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2009.10.024_bib17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0264-410X(96)00170-3","article-title":"Systemic immediate-type reactions to gelatin included in Japanese encephalitis vaccines","volume":"15","author":"Sakaguchi","year":"1997","journal-title":"Vaccine"},{"issue":"19","key":"10.1016\/j.vaccine.2009.10.024_bib18","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0264-410X(99)00480-6","article-title":"IgE sensitization to gelatin: the probable role of gelatin-containing diphtheria\u2013tetanus\u2013acellular pertussis (DTaP) vaccines","volume":"18","author":"Sakaguchi","year":"2000","journal-title":"Vaccine"},{"issue":"9021","key":"10.1016\/j.vaccine.2009.10.024_bib19","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0140-6736(05)66156-9","article-title":"Neurological complications and Japanese encephalitis vaccination","volume":"348","author":"Plesner","year":"1996","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2009.10.024_bib20","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0889-8561(03)00102-4","article-title":"Allergic reactions to Japanese encephalitis vaccine","volume":"23","author":"Plesner","year":"2003","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.vaccine.2009.10.024_bib21","series-title":"26th annual meeting of the European society for paediatric infectious diseases, Graz, Austria. Book of abstracts","article-title":"A Vero cell derived. Inactivated Japanese encephalitis (JE) vaccine IC51 in clinical development for pediatric use","author":"Schuller","year":"2008"},{"issue":"34","key":"10.1016\/j.vaccine.2009.10.024_bib22","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1016\/j.vaccine.2008.05.081","article-title":"Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 six and 12 month results of a multicenter follow-up phase 3 study","volume":"26","author":"Schuller","year":"2008","journal-title":"Vaccine"},{"issue":"33","key":"10.1016\/j.vaccine.2009.10.024_bib23","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1016\/j.vaccine.2009.05.034","article-title":"Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: a single-blind, randomized, controlled Phase 3 study","volume":"27","author":"Kaltenb\u00f6ck","year":"2009","journal-title":"Vaccine"},{"issue":"48","key":"10.1016\/j.vaccine.2009.10.024_bib24","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1016\/j.vaccine.2008.08.056","article-title":"Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51","volume":"26","author":"Schuller","year":"2008","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2009.10.024_bib25","first-page":"149","article-title":"Changes in dengue and Japanese encephalitis (JE) antibody after JE vaccination","volume":"21","author":"Quina","year":"1978","journal-title":"Biken J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09015412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09015412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T06:32:13Z","timestamp":1558593133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09015412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0264410X09015412"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.10.024","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1168504.630698","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}